May 14, 2020
Cardiol Therapeutics has entered into an agreement with a syndicate of underwriters led by Canaccord Genuity Corp. to increase the...
May 13, 2020
Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) has entered into an agreement with Canaccord Genuity.
May 6, 2020
Cardiol Therapeutics is pleased to announce the filing of a new patent application covering the use of cannabidiol (CBD) to...
April 14, 2020
Results showed a greater than 100-fold increase in uptake of Cardiol's nanoparticles in heart failure hearts compared with control hearts
April 1, 2020
Data Accepted for Presentation at the American College of Cardiology Annual Meeting
March 27, 2020
Cardiol Therapeutics Inc. filed its audited Year-end Financial Statements and Management's Discussion and Analysis for the year ended December 31,...
March 26, 2020
Cardiol Therapeutics CEO David Elsley joined the Investing News Network to discuss the company’s recent supply agreement.